GUERBET (GBT.PA) Stock Fundamental Analysis

EPA:GBT • FR0000032526

13.72 EUR
+0.02 (+0.15%)
Last: Feb 18, 2026, 04:53 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GBT. GBT was compared to 67 industry peers in the Health Care Equipment & Supplies industry. The financial health of GBT is average, but there are quite some concerns on its profitability. GBT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • GBT had positive earnings in the past year.
  • In the past year GBT had a positive cash flow from operations.
  • Of the past 5 years GBT 4 years were profitable.
  • In the past 5 years GBT always reported a positive cash flow from operatings.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • With a Return On Assets value of 0.76%, GBT is not doing good in the industry: 65.67% of the companies in the same industry are doing better.
  • The Return On Equity of GBT (2.06%) is worse than 65.67% of its industry peers.
  • GBT has a worse Return On Invested Capital (3.15%) than 67.16% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 9.66%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.15%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 65.67% of the companies in the same industry.
  • GBT's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 4.19%, GBT is doing worse than 67.16% of the companies in the same industry.
  • GBT's Operating Margin has declined in the last couple of years.
  • The Gross Margin of GBT (78.03%) is better than 89.55% of its industry peers.
  • In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
  • Compared to 1 year ago, GBT has about the same amount of shares outstanding.
  • The number of shares outstanding for GBT has been increased compared to 5 years ago.
  • GBT has a worse debt/assets ratio than last year.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • GBT has an Altman-Z score of 2.05. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GBT has a Altman-Z score (2.05) which is in line with its industry peers.
  • The Debt to FCF ratio of GBT is 8.94, which is on the high side as it means it would take GBT, 8.94 years of fcf income to pay off all of its debts.
  • GBT has a Debt to FCF ratio (8.94) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
  • GBT's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. GBT is outperformed by 79.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Altman-Z 2.05
ROIC/WACC0.45
WACC6.93%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.32 indicates that GBT has no problem at all paying its short term obligations.
  • GBT has a better Current ratio (2.32) than 65.67% of its industry peers.
  • A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
  • The Quick ratio of GBT (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • The earnings per share for GBT have decreased strongly by -77.27% in the last year.
  • GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
  • The Revenue has decreased by -2.01% in the past year.
  • Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

  • GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
  • GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-96.34%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • GBT is valuated rather expensively with a Price/Earnings ratio of 22.87.
  • GBT's Price/Earnings ratio is a bit cheaper when compared to the industry. GBT is cheaper than 65.67% of the companies in the same industry.
  • GBT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.27.
  • Based on the Price/Forward Earnings ratio of 97.03, the valuation of GBT can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GBT indicates a slightly more expensive valuation: GBT is more expensive than 76.12% of the companies listed in the same industry.
  • GBT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.16.
Industry RankSector Rank
PE 22.87
Fwd PE 97.03
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • GBT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GBT is cheaper than 97.01% of the companies in the same industry.
  • GBT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GBT is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.89
EV/EBITDA 3.87
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as GBT's earnings are expected to decrease with -10.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%

4

5. Dividend

5.1 Amount

  • GBT has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
  • The stock price of GBT dropped by -20.79% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • GBT's Dividend Yield is rather good when compared to the industry average which is at 1.14. GBT pays more dividend than 83.58% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, GBT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

  • The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

  • GBT pays out 81.59% of its income as dividend. This is not a sustainable payout ratio.
  • GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (2/18/2026, 4:53:17 PM)

13.72

+0.02 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23
Earnings (Next)03-11
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap173.42M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts40
Price Target13.26 (-3.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.75%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-87.44%
EPS NY rev (3m)-87.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 22.87
Fwd PE 97.03
P/S 0.21
P/FCF 3.89
P/OCF 1.85
P/B 0.46
P/tB 0.63
EV/EBITDA 3.87
EPS(TTM)0.6
EY4.37%
EPS(NY)0.14
Fwd EY1.03%
FCF(TTM)3.53
FCFY25.71%
OCF(TTM)7.4
OCFY53.94%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.45%
ROIC 3.15%
ROICexc 3.64%
ROICexgc 4.3%
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.51%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Debt/EBITDA 3.27
Cap/Depr 66.71%
Cap/Sales 6.05%
Interest Coverage 1.56
Cash Conversion 87.13%
Profit Quality 576.4%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.05
F-Score5
WACC6.93%
ROIC/WACC0.45
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-96.34%
EPS Next 2Y-76.56%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the fundamental rating for GBT stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.


What is the valuation status of GUERBET (GBT.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


What is the financial health of GUERBET (GBT.PA) stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


Is the dividend of GUERBET sustainable?

The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.